Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

September’s top stories: Positive opinion for Trelegy Ellipta, Teva agreed to sell assets in women’s health business

GSK and Innoviva received a positive opinion from CHMP for Trelegy Ellipta to treat COPD, and Teva agreed to sell assets in global women’s health business for $1.38bn. Pharmaceutical-technology.com wraps up key headlines from September.

Go Top